Recent news on Olmetec

Astellas and Daiichi Sankyo figures fail to dazzle  -  May 16, 2007
Pharma Times (subscription),More pleasing for the firm was the performance of the antihypertensive agent Benicar/Olmetec (olmesartan), in Japan and Europe, which rose 73.5% to 160.3

Daiichi Sankyo sets challenging sales targets for Europe  -  Apr 3, 2007
Pharma Times (subscription),...co-developed with Eli Lilly, while a combination antihypertensive consisting of the firm's best-selling Benicar/Olmetec (olmesartan) and amlodipine will

DAIICHI SANKYO - Merger for Worldwide Growth Successfully Completed  -  Apr 5, 2007
Drug Newswire (press release),Apart from Prasugrel, a combination drug consisting of Olmesartan and Amlodipine as well as the high-dose preparation OLMETEC Plus(R) (combination drug

DAIICHI SANKYO - Merger for Worldwide Growth Successfully Completed  -  Apr 1, 2007
Earthtimes.orgApart from Prasugrel, a combination drug consisting of Olmesartan andAmlodipine as well as the high-dose preparation OLMETEC Plus(R) (combinationdrug based

Daiichi Sankyo: Consolidated Financial Results for the First Nine ...  -  Jan 31, 2007
PharmaLive.com (press release),Sales were firm due to significant growth in antihypertensive agent, Olmetec® (in Japan), Benicar® (in US) and Olmetec® (in Europe), as well as steady

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional